Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4541175011 | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4541176012 | Monoclonal antibody antineoplastic agent | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Some | ||
| Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | est un(e) (attribut) | Medicinal product acting as antineoplastic agent (product) | true | Inferred relationship | Some | ||
| Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | est un(e) (attribut) | Product containing monoclonal antibody (product) | true | Inferred relationship | Some | ||
| Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | a pour principe actif (attribut) | Monoclonal antibody (substance) | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing enfortumab vedotin (medicinal product) | est un(e) (attribut) | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Some | |
| Product containing isatuximab (medicinal product) | est un(e) (attribut) | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Some | |
| Sacituzumab govitecan-containing product | est un(e) (attribut) | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Some | |
| Product containing trastuzumab (medicinal product) | est un(e) (attribut) | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Some | |
| Product containing ibritumomab tiuxetan (medicinal product) | est un(e) (attribut) | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Some | |
| gemtuzumab ozogamicine | est un(e) (attribut) | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Some | |
| Product containing alemtuzumab (medicinal product) | est un(e) (attribut) | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Some | |
| Product containing tositumomab (medicinal product) | est un(e) (attribut) | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Some | |
| Product containing cetuximab (medicinal product) | est un(e) (attribut) | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Some | |
| Product containing bevacizumab (medicinal product) | est un(e) (attribut) | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Some | |
| Product containing panitumumab (medicinal product) | est un(e) (attribut) | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Some | |
| Product containing zanolimumab (medicinal product) | est un(e) (attribut) | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Some | |
| Product containing oregovomab (medicinal product) | est un(e) (attribut) | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Some | |
| Product containing naptumomab (medicinal product) | est un(e) (attribut) | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Some | |
| Product containing ofatumumab (medicinal product) | est un(e) (attribut) | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Some | |
| Product containing nivolumab (medicinal product) | est un(e) (attribut) | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Some | |
| pertuzumab | est un(e) (attribut) | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Some | |
| Product containing ramucirumab (medicinal product) | est un(e) (attribut) | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Some | |
| Product containing ipilimumab (medicinal product) | est un(e) (attribut) | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Some | |
| Product containing brentuximab vedotin (medicinal product) | est un(e) (attribut) | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Some | |
| Product containing atezolizumab (medicinal product) | est un(e) (attribut) | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Some | |
| Product containing avelumab (medicinal product) | est un(e) (attribut) | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Some | |
| Product containing pembrolizumab (medicinal product) | est un(e) (attribut) | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Some | |
| Product containing olaratumab (medicinal product) | est un(e) (attribut) | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Some | |
| Product containing durvalumab (medicinal product) | est un(e) (attribut) | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Some | |
| Product containing dinutuximab (medicinal product) | est un(e) (attribut) | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Some | |
| Product containing inotuzumab ozogamicin (medicinal product) | est un(e) (attribut) | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Some | |
| Product containing mogamulizumab (medicinal product) | est un(e) (attribut) | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Some | |
| Product containing blinatumomab (medicinal product) | est un(e) (attribut) | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Some | |
| Polatuzumab vedotin-containing product | est un(e) (attribut) | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Some | |
| Product containing obinutuzumab (medicinal product) | est un(e) (attribut) | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Some | |
| Product containing rituximab (medicinal product) | est un(e) (attribut) | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Some | |
| Moxetumomab pasudotox-containing product | est un(e) (attribut) | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Some | |
| Necitumumab-containing product | est un(e) (attribut) | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Some | |
| Daratumumab-containing product | est un(e) (attribut) | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Some | |
| Elotuzumab-containing product | est un(e) (attribut) | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Some | |
| Cemiplimab-containing product | est un(e) (attribut) | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Some | |
| Tafasitamab-containing product | est un(e) (attribut) | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Some | |
| Product containing belantamab mafodotin (medicinal product) | est un(e) (attribut) | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Some | |
| Naxitamab-containing product | est un(e) (attribut) | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Some | |
| Margetuximab-containing product | est un(e) (attribut) | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Some | |
| Product containing trastuzumab deruxtecan (medicinal product) | est un(e) (attribut) | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Some | |
| Product containing dostarlimab (medicinal product) | est un(e) (attribut) | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Some | |
| Loncastuximab tesirine-containing product | est un(e) (attribut) | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Some | |
| Trastuzumab emtansine-containing product | est un(e) (attribut) | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Some | |
| médicament contenant amivantamab | est un(e) (attribut) | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Some |
This concept is not in any reference sets
FHIR